FDAnews
www.fdanews.com/articles/98343-india-rsquo-s-cipla-new-prescription-needed

India’s Cipla: New Prescription Needed?

September 11, 2007

Over the years, India’s pharmaceutical companies have specialized in making low-cost versions of Western drugs. One of the most successful has been Cipla Ltd. During the 2001 anthrax scare in the U.S., for instance, the Mumbai-based company won attention by offering to provide an inexpensive generic version of Bayer’s Cipro, the most powerful anti-anthrax medicine.
Business Week